| P2093 | author name string | Chien-Kai Wang | |
| | Chen-Jei Tai | |
| | Cheng-Jeng Tai | |
| | Yu-Jia Chang | |
| | Lu-Min Chen | |
| | Ming-Te Huang | |
| | Weu Wang | |
| | Chun-Te Wu | |
| | Feng-Hsiang Chiu | |
| | Jen-Chih Lee | |
| P2860 | cites work | The epithelial-mesenchymal transition: new insights in signaling, development, and disease | Q24683758 |
| | Epithelial-mesenchymal transitions in tumour progression | Q27860487 |
| | Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells | Q71637914 |
| | Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis | Q72033788 |
| | Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study | Q73496814 |
| | The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies | Q73981622 |
| | Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants | Q74037417 |
| | Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas | Q77430275 |
| | The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study | Q80964851 |
| | Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer | Q81005876 |
| | Ovarian cancer | Q82238526 |
| | Cancer statistics, 2012 | Q27860574 |
| | Epithelial-mesenchymal transitions in development and disease | Q27860630 |
| | The roles of protein C and thrombomodulin in the regulation of blood coagulation | Q28630616 |
| | Cancer statistics, 2009 | Q29547625 |
| | Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 |
| | Optimal chemotherapy treatment for women with recurrent ovarian cancer | Q33302771 |
| | Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN | Q33321821 |
| | Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum | Q33389720 |
| | Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays | Q33917668 |
| | Fibronectin at a glance | Q34150530 |
| | Precursor lesions of ovarian epithelial malignancy | Q34156377 |
| | Downregulation of thrombomodulin, a novel target of Snail, induces tumorigenesis through epithelial-mesenchymal transition | Q34178127 |
| | EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer | Q34202046 |
| | Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission | Q34735674 |
| | The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma | Q35185928 |
| | Epithelial-mesenchymal transition in cervical carcinoma. | Q35747467 |
| | Molecular approaches to personalizing management of ovarian cancer | Q35760160 |
| | Epithelial-mesenchymal transitions: twist in development and metastasis | Q35856121 |
| | Origins and molecular pathology of ovarian cancer | Q36068263 |
| | Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival | Q36614638 |
| | Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response | Q36948577 |
| | The role of thrombomodulin in malignancy | Q37000493 |
| | Epidemiology of ovarian cancer | Q37358065 |
| | Ovarian cancer: an overview | Q37611774 |
| | Epigenetics of ovarian cancer: from the lab to the clinic | Q37737449 |
| | The role of targeted therapy in ovarian cancer | Q37937859 |
| | Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration. | Q38041781 |
| | The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration | Q38274559 |
| | Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer | Q39683515 |
| | Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma | Q39750121 |
| | Development of an ovarian cancer symptom index: possibilities for earlier detection. | Q39777813 |
| | Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. | Q40111238 |
| | Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma. | Q43261091 |
| | Nicotine enhances colon cancer cell migration by induction of fibronectin. | Q52297901 |
| | Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. | Q53358319 |
| | Nicotine promotes cell migration through alpha7 nicotinic acetylcholine receptor in gastric cancer cells. | Q54386234 |
| | The carboxyl tail of Cx43 augments p38 mediated cell migration in a gap junction-independent manner | Q54654755 |
| P433 | issue | 6 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 3743-3751 | |
| P577 | publication date | 2013-08-06 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Thrombomodulin mediates the progression of epithelial ovarian cancer cells | |
| P478 | volume | 34 | |